ION

Ionis Pharmaceuticals is a leading biotechnology company specializing in the discovery and development of RNA-targeted therapeutics. The company utilizes its proprietary antisense technology platform to create medicines that treat a wide range of diseases, including rare disorders, cardiovascular conditions, and neurological diseases. Ionis has successfully brought several blockbuster drugs to market, most notably Spinraza for spinal muscular atrophy, and maintains one of the largest pipelines in the biotech industry. Its business model combines internal drug development with high-value strategic partnerships with major pharmaceutical companies like Biogen, AstraZeneca, and GSK. Headquartered in Carlsbad, California, Ionis continues to innovate in the field of genomic medicine through its advanced ligand-conjugated antisense (LICA) technology.